Meningioma

Meningioma is a type of tumor that grows from the meninges, the three layers of tissue that wrap and protect the brain and spinal cord. Some tumors are benign and don’t need immediate treatment. But some meningiomas are atypical, meaning the cells act more aggressively, grow more quickly, and require treatment. Our neurosurgeons, neurologists, and radiation oncologists work together to assess the growth and appearance of these tumors and create a personalized treatment plan for you.

Clinical Trials and Research Studies

Phase 3

ACNS1931: A Phase 3 Study of Selumetinib (NSC# 748727 IND# 77782) or Selumetinib in Combination with Vinblastine for non-NF1 non-TSC Patients with Recurrent or Progressive Low-Grade Gliomas (LGGs) Lacking BRAFV600E or IDH1 Mutations

Learn More

Phase 2

DAY101-001/PNOC026/FIREFLY-1: A Phase 2 Open-Label Multicenter Study to Evaluate the Safety and Efficacy of the Oral Pan-RAF Inhibitor DAY101 in Pediatric Patients with BRAF-Altered Recurrent or Progressive Low-Grade Glioma

Learn More

Phase 6

GBM Agile Trial

Learn More

Phase 3

A Pivotal Randomized Open-Label Study of Optune (TTFields 200khz) Concomitant with Radiation Therapy and Temozolomide for the Treatment of Newly Diagnosed Glioblastoma

Learn More